Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 July, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 543349 | NSE: AMIORG

Fundamental Analysis of Ami Organics Ltd

Basic Stock Data

Last Updated: July 20, 2024, 10:18 pm

Market Cap 5,369 Cr.
Current Price 1,313
High / Low1,470/1,004
Stock P/E90.2
Book Value 183
Dividend Yield0.23 %
ROCE16.0 %
ROE9.39 %
Face Value 10.0
PEG Ratio-6.01

Data Source: screener.in

Competitors of Ami Organics Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Shilpa Medicare Ltd 6,162 Cr. 630685/296200 2080.00 %5.27 %1.72 % 1.00
IOL Chemicals & Pharmaceuticals Ltd 2,367 Cr. 403536/33117.5 2741.24 %12.3 %8.69 % 10.0
Beta Drugs Ltd 1,250 Cr. 1,3011,595/72834.3 1630.00 %36.0 %29.6 % 10.0
Bliss GVS Pharma Ltd 1,157 Cr. 110150/77.412.3 92.40.45 %14.4 %10.2 % 1.00
Suven Life Sciences Ltd 2,736 Cr. 125145/60.8 12.40.00 %36.4 %36.3 % 1.00
Industry Average16,842.06 Cr1,291.1543.43209.070.36%17.24%16.50%6.44

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales93113122141144131147152186154172166225
Expenses709195111118108119122146120148140182
Operating Profit23222730262328314134252743
OPM %25%20%22%21%18%17%19%20%22%22%14%16%19%
Other Income01010113-01-3031
Interest1330100111132
Depreciation1222333334445
Profit before tax21182329222026303731-102437
Tax %25%24%22%32%4%27%26%25%26%28%-71%25%31%
Net Profit15141719211519222722-171826
EPS in Rs4.894.364.795.345.844.085.236.117.465.41-5.114.546.82

Last Updated: July 11, 2024, 12:04 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: July 11, 2024, 12:04 am

MonthMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales160188239240341520617717
Expenses137157196198260415493589
Operating Profit2331424280105123128
OPM %14%16%18%17%24%20%20%18%
Other Income0302134-25
Interest33566626
Depreciation12344101216
Profit before tax19283535729111282
Tax %35%35%34%21%25%21%26%41%
Net Profit1218232754728349
EPS in Rs80.33123.3322.1926.1617.1419.7522.8611.60
Dividend Payout %0%0%0%0%0%15%13%26%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)50.00%27.78%17.39%100.00%33.33%15.28%-40.96%
Change in YoY Net Profit Growth (%)0.00%-22.22%-10.39%82.61%-66.67%-18.06%-56.24%

Growth

Compounded Sales Growth
10 Years:%
5 Years:25%
3 Years:28%
TTM:16%
Compounded Profit Growth
10 Years:%
5 Years:21%
3 Years:3%
TTM:-29%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:16%
Return on Equity
10 Years:%
5 Years:17%
3 Years:14%
Last Year:9%

Last Updated: July 17, 2024, 4:53 pm

Balance Sheet

Last Updated: July 11, 2024, 12:04 am

MonthMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Equity Capital22101032363637
Reserves375672101135486558637
Borrowings2744545913714217
Other Liabilities43547761110136169205
Total Liabilities1091552132324136597671,096
Fixed Assets28327985186205259427
CWIP11302120330125
Investments13221220
Other Assets6891131133225450477543
Total Assets1091552132324136597671,096

Reserves and Borrowings Chart

Cash Flow

MonthMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity 298152728-1266125
Cash from Investing Activity -19-25-21-24-101-121-33-365
Cash from Financing Activity -7156072140-12239
Net Cash Flow3-2-03-1820-1

Free Cash Flow

MonthMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-4.00-13.00-12.00-17.00-57.00104.00119.00-89.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days839711686129115136
Inventory Days768995148123150131
Days Payable148154168146172158157
Cash Conversion Cycle1131438880107111
Working Capital Days46646886119141149
ROCE %38%34%27%33%24%21%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters41.05%41.05%41.05%41.05%39.41%39.41%39.41%39.41%38.93%39.91%39.91%
FIIs2.51%1.34%2.23%1.84%5.76%6.41%6.36%6.73%7.15%11.66%8.98%
DIIs6.30%3.81%5.63%4.20%3.61%3.73%3.63%5.12%5.95%7.58%6.80%
Public50.14%53.80%51.08%52.91%51.22%50.47%50.62%48.74%47.97%40.85%44.31%
No. of Shareholders92,45997,54793,92287,04485,56380,53178,78670,35272,89783,34495,784

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund441,0221.4451.311572024-07-20280805.73%
UTI Small Cap Fund324,2261.0137.721572024-07-20206413.38%
Tata ELSS Tax Saver Fund298,0000.8734.671572024-07-20189708.92%
ITI Small Cap Fund145,8020.8116.961572024-07-2092767.52%
Union Small Cap Fund117,7131.0213.691572024-07-2074876.43%
UTI Healthcare Fund110,0001.3912.81572024-07-2069963.69%
Edelweiss Recently Listed IPO Fund100,0001.2411.631572024-07-2063594.27%
Tata India Pharma & HealthCare Fund50,0000.695.821572024-07-2031747.13%
Taurus Infrastructure Fund3350.480.041572024-07-20113.38%
Motilal Oswal S&P BSE Healthcare ETF1570.180.021572024-07-200%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)11.6722.8621.0317.148.72
Diluted EPS (Rs.)11.6622.8621.0317.148.72
Cash EPS (Rs.)17.5626.2522.5118.4729.51
Book Value[Excl.RevalReserv]/Share (Rs.)185.13163.01143.3452.99106.49
Book Value[Incl.RevalReserv]/Share (Rs.)185.13163.01143.3452.99106.49
Revenue From Operations / Share (Rs.)194.54169.26142.75108.13228.23
PBDIT / Share (Rs.)36.8734.8329.6225.8841.77
PBIT / Share (Rs.)32.5231.4526.8624.5538.42
PBT / Share (Rs.)22.2130.7925.1022.7733.10
Net Profit / Share (Rs.)13.2122.8619.7517.1426.16
NP After MI And SOA / Share (Rs.)11.6022.8619.7517.1426.16
PBDIT Margin (%)18.9520.5820.7523.9318.30
PBIT Margin (%)16.7118.5718.8122.7016.83
PBT Margin (%)11.4118.1817.5821.0514.50
Net Profit Margin (%)6.7813.5013.8315.8511.46
NP After MI And SOA Margin (%)5.9613.5013.8315.8511.46
Return on Networth / Equity (%)6.3414.0213.7732.3424.56
Return on Capital Employeed (%)14.7918.9618.4731.2829.38
Return On Assets (%)3.9010.8610.9113.0611.84
Long Term Debt / Equity (X)0.160.000.000.430.17
Total Debt / Equity (X)0.320.010.000.700.48
Asset Turnover Ratio (%)0.770.860.971.061.09
Current Ratio (X)1.742.893.321.301.28
Quick Ratio (X)1.192.152.450.930.72
Inventory Turnover Ratio (X)3.192.993.273.103.03
Dividend Payout Ratio (NP) (%)0.0013.120.000.000.00
Dividend Payout Ratio (CP) (%)0.0011.430.000.000.00
Earning Retention Ratio (%)0.0086.880.000.000.00
Cash Earning Retention Ratio (%)0.0088.570.000.000.00
Interest Coverage Ratio (X)22.8952.6216.8514.517.85
Interest Coverage Ratio (Post Tax) (X)14.6035.5312.2310.615.92
Enterprise Value (Cr.)4208.123184.013543.730.000.00
EV / Net Operating Revenue (X)5.875.166.810.000.00
EV / EBITDA (X)30.9525.0932.830.000.00
MarketCap / Net Operating Revenue (X)5.635.257.000.000.00
Retention Ratios (%)0.0086.870.000.000.00
Price / BV (X)5.995.456.970.000.00
Price / Net Operating Revenue (X)5.635.257.000.000.00
EarningsYield0.010.020.010.000.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 1,553.53

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 18.32% compared to the current price 1313

Intrinsic Value: 1,320.34

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 0.56% compared to the current price 1313

Last 5 Year EPS CAGR: -15.01%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 25.29%, which is a positive sign.
  2. The company has higher reserves (260.25 cr) compared to borrowings (67.88 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (377.75 cr) and profit (59.25 cr) over the years.
  1. The stock has a high average Working Capital Days of 96.14, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 67.29, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ami Organics Ltd:
    1. Net Profit Margin: 6.78%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 14.79% (Industry Average ROCE: %)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 6.34% (Industry Average ROE: %)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 14.60
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.19
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 90.2 (Industry average Stock P/E: )
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.32
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company

Ami Organics Ltd. is a Public Limited Listed company incorporated on 12/06/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2007PLC051093 and registration number is 051093. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 520.14 Cr. and Equity Capital is Rs. 36.44 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot No. 440/4, 5 & 6, Surat Gujarat 394230investorinfo@amiorganics.com
http://www.amiorganics.com
Management
NamePosition Held
Mr. Nareshkumar Ramjibhai PatelExe.Chairman & Mng.Director
Mr. Chetankumar Chhaganlal VaghasiaWhole Time Director
Mr. Virendra Nath MishraWhole Time Director
Mr. Ram Mohan Rao LocandeWhole Time Director
Mrs. Richa Manoj GoyalIndependent Director
Mr. Hetal Madhukant GandhiIndependent Director
Mr. Girikrishna Suryakant ManiarIndependent Director
Dr. Anita BandyopadhyayIndependent Director

FAQ

What is the latest fair value of Ami Organics Ltd?

The latest fair value of Ami Organics Ltd is ₹1553.53.

What is the Market Cap of Ami Organics Ltd?

The Market Cap of Ami Organics Ltd is 5,369 Cr..

What is the current Stock Price of Ami Organics Ltd as on 20 July 2024?

The current stock price of Ami Organics Ltd as on 20 July 2024 is 1,313.

What is the High / Low of Ami Organics Ltd stocks in FY 2024?

In FY 2024, the High / Low of Ami Organics Ltd stocks is 1,470/1,004.

What is the Stock P/E of Ami Organics Ltd?

The Stock P/E of Ami Organics Ltd is 90.2.

What is the Book Value of Ami Organics Ltd?

The Book Value of Ami Organics Ltd is 183.

What is the Dividend Yield of Ami Organics Ltd?

The Dividend Yield of Ami Organics Ltd is 0.23 %.

What is the ROCE of Ami Organics Ltd?

The ROCE of Ami Organics Ltd is 16.0 %.

What is the ROE of Ami Organics Ltd?

The ROE of Ami Organics Ltd is 9.39 %.

What is the Face Value of Ami Organics Ltd?

The Face Value of Ami Organics Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Ami Organics Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE